We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Consort Medical Plc | LSE:CSRT | London | Ordinary Share | GB0000946276 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1,010.00 | 1,005.00 | 1,010.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMCSRT
RNS Number : 8149Q
Consort Medical PLC
02 December 2016
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) -------------------------------------------------- 1. Identity of the issuer or the underlying CONSORT MEDICAL PLC issuer of existing shares to which voting rights are attached: (ii) ---------------------------------------------------------------------------- ------------------------------------------ 2 Reason for the notification (please tick the appropriate box or boxes): ------------------------------------------------------------------------------------------------------------------------ An acquisition or disposal of voting rights x -------------------------------------------------------------------------------- -------------------------------------- An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached -------------------------------------------------------------------------------- -------------------------------------- An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments -------------------------------------------------------------------------------- -------------------------------------- An event changing the breakdown of voting rights -------------------------------------------------------------------------------- -------------------------------------- Other (please specify): ---------------------------------------------------------------------- -------- -------------------------------------- 3. Full name of person(s) subject Neptune Investment Management Limited to the notification obligation: (iii) ------------------------------------------------------------------------ ---------------------------------------------- 4. Full name of shareholder(s) n/a (if different from 3.):(iv) ------------------------------------------------------------------------ ---------------------------------------------- 5. Date of the transaction and date 30(th) November 2016 on which the threshold is crossed or reached: (v) ------------------------------------------------------------------------ ---------------------------------------------- 6. Date on which issuer notified: 1(st) December 2016 ------------------------------------------------------------------------ ---------------------------------------------- 7. Threshold(s) that is/are crossed Below 5% or reached: (vi, vii) ------------------------------------------------------------------------ ---------------------------------------------- 8. Notified details: ----------------------------------------------------------------------------------------------------------------------- A: Voting rights attached to shares (viii, ix) ----------------------------------------------------------------------------------------------------------------------- Class/type Situation previous Resulting situation after the triggering of to the triggering transaction shares transaction if possible using the ISIN CODE -------------- -------------------------------- --------------------------------------------------------------------- Number Number Number Number of voting % of voting rights of of of shares rights (x) Shares Voting Rights -------------- --------------- --------------- ------------- ------------------------- --------------------------- Direct Direct Indirect Direct Indirect (xi) (xii) -------------- ----------- ----------- ------------- ------------ ----------- ------------ ------------- GB0000946276 1,951,594 1,951,594 n/a 3.97% n/a ------------- ------------ ----------- ------------ ------------- 2,563,867 2,563,867 -------------- --------------- --------------- ----------- ---------- ----------- -------- ----------- B: Qualifying Financial Instruments ----------------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ----------------------------------------------------------------------------------------------------------------------- Type of financial Expiration Exercise/ Number of voting % of voting instrument date (xiii) Conversion Period rights that may rights (xiv) be acquired if the instrument is exercised/ converted. ------------------ ------------- ------------------------------ --------------------------- ----------------------- n/a n/a n/a n/a n/a ------------------ ------------- ------------------------------ --------------------------- ----------------------- C: Financial Instruments with similar economic effect to Qualifying Financial Instruments (xv, xvi) ----------------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ----------------------------------------------------------------------------------------------------------------------- Type of Exercise Expiration Exercise/ Number of voting % of voting rights financial price date (xvii) Conversion rights instrument (xix, xx) instrument period refers to (xviii) ---------------- ------------- ------------- --------------- --------------------------- ------------------------- n/a n/a n/a n/a n/a Nominal Delta ---------------- ------------- ------------- --------------- --------------------------- ------------ ----------- n/a n/a -------------- ----------- ----------- ----------- ---------- ----------- ------------ ----------- Total (A+B+C) ----------------------------------------------------------------------------------------------------------------------- Number of voting rights Percentage of voting rights -------------------------------------------------- ------------------------------------------------------------------- 1,951,594 3.97% -------------------------------------------------- ------------------------------------------------------------------- 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: (xxi) --------------------------------------------------------------------------------------- n/a Proxy Voting: --------------------------------------------------------------------------------------- 10. Name of the proxy holder: n/a ---------------------------------------------------------------------- --------------- 11. Number of voting rights proxy holder will n/a cease to hold: ---------------------------------------------------------------------- --------------- 12. Date on which proxy holder will cease to n/a hold voting rights: ---------------------------------------------------------------------- --------------- 13. Additional information: n/a ---------------------------------------------------------------------- --------------- 14. Contact name: Kieran Raymond ---------------------------------------------------------------------- --------------- 15. Contact telephone number: 020 3249 0197 ---------------------------------------------------------------------- ---------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLTTBLTMBTMMTF
(END) Dow Jones Newswires
December 02, 2016 04:25 ET (09:25 GMT)
1 Year Consort Medical Chart |
1 Month Consort Medical Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions